OncoPep is developing PVX-410, an investigational cancer vaccine designed to stop disease progression in multiple myeloma. In addition to smoldering multiple myeloma (SMM), our investigational peptide portfolio more broadly targets multiple myeloma, triple negative breast cancer (TNBC) and several s
Member count: 11-50
Total raised: $6.9M
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | Cobro Vent... | cobroventu... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 28.08.2014 | Series B | $6.9M | - | finsmes.co... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 09.12.2021 | OncoPep Pu... | CAMBRIDGE, MA, OncoPep, a de... | - | - | vcnewsdail... |
| 28.08.2014 | OncoPep Cl... | OncoPep, Inc., a Boston, MA-ba... | USA | - | finsmes.co... |
| 28.08.2014 | OncoPep Ra... | BOSTON, MA, OncoPep, Inc., t... | - | - | vcnewsdail... |